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A complete disappearance of orcein positive material 
was observed in the superficial dermis of patients suf-
fering from Lichen sclerosus et atrophicus. 
An elastase-type protease was isolated and partially 
purified from Triton X-IOO extracts of human vulvar 
fibroblasts by gel permeation chromatography. It pre-
sents the characteristics of a metalloenzyme hydrolyzing 
Succinoyl tri-alanine paranitroanilide maximally at pH 
8.0 and is also active towards insoluble elastin. When 
partially purified enzyme is directly applied on to rabbit 
skin sections or when injected intradermally to young 
rabbits, it produces appreciable degradation of elastic 
fibers. 
The involvement of this protease in the disappearance 
of elastic fibers in Lichen sclerosus et atrophicus is pos-
tulated. 
Elastin, as the main amorphous component of elastic fibers, 
is found in large amounts in ligamentum nuchae, human arterial 
vessels and lung parenchyma [1,2]; it is also present but in lower 
quantities in adult skin [3] and to date it seems that most 
connective tissue cell types [4-6] have the potential ability of 
synthetizing elastin. Histological observations of the human 
vulvar dermis using classical stains for elastin led us to conclude 
that there are large amounts of this connective tissue protein 
present in this particular tissue. On the other hand, a nearly 
complete disappearance of orcein positive or elastin-type ma-
terial was observed in the superficial dermis of patients suffering 
from Lichen sclerosus et atrophicus (LSA) associated with a 
"homogenization" of collagen and lymphocytic infiltration [7]. 
With respect to its specific physical properties, elastin is 
resistant to most hydrolytic and proteolytic cleavage [8]. In 
vivo, the catabolism of elastic tissue is due mainly to the 
enzymatic action of endopeptidases designated as elastases [9]. 
Among mammalian cells, polymorphonuclear neutrophils, mac-
rophages, monocytes, and platelets contain such a type of 
protease activity [10] and more recently we also evidenced the 
presence of an elastase-type enzyme in human skin fibroblasts 
[Ill 
In the present investigation, we were able to isolate and 
partially characterize such an elastase-type protease from fibro-
blast cells originating in human vulva. The possible involve-
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ment of human vulva fibroblast elastase-type protease in skin 
and vulvar elastic tissue destruction was postulated on the basis 
of the in vitro and in vivo activity of this endopeptidase. 
MATERIALS AND METHODS 
Alpha,antitrypsin (A 6388), leupeptin (L 3631), pepstatin (P 4265) , 
phenylmethylsulfonylfluoride Pmsf (P 7626), Orcein (0 3626) Carmin 
Indigo, Benzoyl Arginine paranitroanilide (BANA) , Benzoyl T yrosine 
paranitroanilide (BTNA) were purchased from S igma Chemicals (S t 
Lou is, Missouri 63178 U.S.A.). Dulbecco's phosphate buffered saline 
(PBS 310-4080), Eagle Minimum Essential Medium (MEM 310 4080), 
Antibiotic antimytotic solution: ABAM (600-5240) and Trypsin EDTA 
(610-5305) came from GIBCO Bio Cult (3 Wash. Road, Paisley, P.A., 
34 EP, Scotland). 
Succinyl trialanine paranitroanilide (Suc(AlahNA) was obtained 
from Precibio (81 rue de la Procession, Rueil-Malmaison, France). 
Porcine pancreatic elastase (60 U/mg) from Eurorga (Villeras-Saclay, 
France) and Brij 35 from Merck (E. Merck, Darmstadt, Germany). 
Other products are of highest purity commercially available. Human 
leucocyte elastase was a gift of Dr H.P. Schnebli (Ciba-Geigy, Basel, 
Switzerland). 
Vulvar Samples 
Mucosal vulvar biopsies from 10 women suffering from histologically 
confirmed LSA were obtained after intradermal injection of a 1% 
xyloca'in solution. The mean age of the patients was 55.8 yr (36-75 yr) 
and the mean dry weight of biopsy samples was 34.7 mg (standard enol' 
on the mean SEM): 4.5). As control samples we performed similar 
biopsies during surgical operations in women suffering from genital 
prolapsus. The mean age of the patients was 43.2 (23-73 yr) and the 
mean dry weight of biopsy samples equal to 43.1 mg (SEM: 5.6). 
Histological Observations 
Classical histological techniques to define elastic fibers were used in 
tissue sections. In our hands, for this particular tissue, the best contrast 
was obtained using a slight modification of the double staining tech-
nique for elastic and collagen fibers as described previously by us [12]. 
Briefly, frozen sections (5-7 f.I.) were postfixed during 30 min with 2% 
glu taraldehyde in 0.2 M phosphate buffer pH 7.35 and exhaustively 
washed with phosphate buffer, distilled water and were dehydrated 
'with increasing concentrations of ethanol up to a 90% v/ v in water. 
Microscopical slides were then dipped in to a 1% filtered orcein solution 
in 90% ethanol containing 1.2% distilled HCI during 4 hI' at 4°C. They 
were then exhaustively washed with 90% ethanol in order to eliminate 
most of the nonspecific staining. Postcoloration (for visualization of 
collagen fibers) were carried out with a 0.4% carmin indigo in a saturated 
picric acid solu tion in water during 30 seconds. Sections were then 
washed, dehydrated in ethanol, cleared in Xylen, and mounted in 
Balsam. Microscopic observations were made using a polyvar Jung 
Reichert photonic microscope. 
Human Vulvar Fibroblast Culture 
Biopsies were immersed into sterile vials contain ing 5 ml of MEM 
buffered to pH 7.40 with a 20 mM solution of N-2 hydroxyethyl 
piperazine N-2 ethane sulfonic acid. 
Each biopsy was then transferred to a Petri dish, washed 3 times 
over a period of 10 min with 5 ml of phosphate buffered saline contain-
ing 5% ABAM solu tion and finally cut in to small pieces (about 2 mm') 
using a razor blade. Each slide with the epidermal side up was then 
carefully laid on to a 25 cm' Falcon cultw'e flask. These flasks were 
kept for half an hour in an upright position to enSUl'e the proper 
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attachment of t issue sa mples. We then added 5 ml or MEM supple-
mented with 1% ABAM solu t ion, 1% glutamine, and containing 10% or 
heat-inactivated newborn calf serum. The medium was changed every 
3 days and under such experimental conditions cell confluency was 
reach e d with in 3-4 weeks. 
Epithelial cells remained firmly attached to the fl ask during trypsin-
ization of the cells (2 ml during 4 min.) and microscopical examination 
of the first (or subsequent) subcult ures indicated the presence of 
fibroblast cells only. 
Determination of Enzyme Activities 
Activities hydrolyzing Benzoyl Tyrosine paranitroaniline and Ben-
zoyl Arginine pamnitroanilide ~ere determined as described [1 3, 14]' 
Succinyl tnalanme paramtroanillde (Suc (Alala NA) was used as syn-
thetic s ubstra te for the determination of elastase activity [15]. 20 ILl of 
a 125 mM solution of Suc(Alah NA in N methyl pyrolidone were added 
to 1 ml of enzyme solu tion in 0.1 M tris HCl buffer, 5 mM CaCl2, 0.02% 
NaNa, 0.1% Brij 35 pH 8.0. The variations in optical density at 410 nm 
wer e recorded as a function of time at 20°C in a spectrophotometer 
BeckInan type Acta C III. Enzyme units are defined as ILmoles of 
substrate hydrolyzed per minute; the results were a lso expressed as ILg 
of porcine pancreatic elastase (60 U / mg) equivalents per mg of protein 
determined according to Lowry et a lusing BSA as standa rd (16). 
Alkali purified insoluble ligamentum nuchae elastin was used as 
substrate for determining elastinolytic activ it ies. 10 mg of elastin and 
enzyme solu tions in 1 ml of 0.1 M carbonate buffer, 5 mM CaCb, 0.01% 
Brij 35, 0.02% NaN:, pH 8.15 were incubated during 6 hI' at 37°C wi th 
occasiona l shaking. The tubes are then centrifuged at 13.800 g for 5 
min and the moles N-terminal amino-acids released quantitated ac-
cording to Rosen et al [17], using a standard curve obta ined with L-
leucine. Appropriate blanks were included in each determination, per-
formed in duplicate. 
The elastinolytic activity of partiaUy purified elastase-type protease 
isolated from human vulvas as compared with those of leukocyte 
elastase was also determined by histological technique. Active en-
zyme (s) solu tionis) (25-100 ILl in 0.1 M Tris-HCI, 5 mM CaCl2 pH 8.0) 
FIG 1. Histology of normal and pathological human vulva. (x 1,000) , 
orcein staining technique [12]. A , Human vu lva in Lichen sclerosus et 
was carefully applied on frozen rabbit skin sections and the microscop-
ical slides were incubated during 6 hI' at 20°C. The sections were 
quickly washed with Tris-HCl buffer and the degradation of elastic 
fibers were visualized after orcein st.aining of microscopical serial sec-
t ions. 
Intradermal Injection of Purified Elastases in Rabbits 
0.5 ml of sterile purified elastase solu t ions (containing the same 
amount of enzyme in uni ts) were injected intradermally in adjacent 
areas in to the back of a young rabbit. Each experiment was repeated 
twice and biopsies were taken 6 hI' aft er injections. The degradation of 
elastic fibers visualized after orcein staining of microscopical sections 
(20-50 on each case) was quantitated by determining the length of such 
fibers on a Reicher t Jung Video Screen. The statistical variations of 
the length of the elastic fibers were evaluated by the Student-Fisher t 
test. 
RESULTS 
Isolation, Partial Purification and Characterization of an 
Elastase-type Protease from Human Vulvar Fibroblasts 
Human vulva fibroblasts, 2.107 cells from the 5th subcultme 
of nonpathological tissue were first washed exhaustively with 
cold phosphate buffered saline (PBS) to elim inate most of the 
adsorbed serum constituants. These cells were then lysed with 
50 ml of 100 mM Tris HCI, 5 mM CaCb, 0.1% Triton X-lOO, 
0.02% sodium azide pH 8.0. The cell extract was first centrifuged 
at 5.300 g for 30 min at 4°C and its elastase activity was 
determined on Suc(Ala)3 NA. It contained in total 23 milliUnits 
(mU) elastase which corresponded to 22.4 J..Lg of porcine pan-
creatic elastase equivalents extractible fro m 2.107 cells. The 
specific elastase activity of this extract is equal to 0.37 J..Lg of 
pancreatic elastase equivalents per mg of protein. No activities 
hydrolyzing either BANA or BTNA were recovered in Triton 
atrophicus (LSA). B, Normal human vu lva. ep ., epidermis; sd, superfi-
cial dennis; and elf: elastic fibers (Q./TOWS). 
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extracts of human vulva fibroblasts. This extract was again 
centrifuged at 48.300 g for 30 min at 4°C and more than 85% of 
the original activity hydrolyzing Suc(Alah NA was recovered 
in the supernatant. The enzyme was found stable when solu-
tions were kept at 4°C at slightly alkaline pH but lost most of 
its activity at pH 4.0; the activity hydrolyzing Suc(Alab NA 
was determined as a function of pH in the range of pH 4.0 to 
10.0. The optimum pH of the enzyme on this substrate is 
situated near pH 8.0 (Fig 1) . 
This cell Triton X-100 extract was concentrated by ultrafil-
tration on a PM 10 membrane and dialysed against many 
changes of cold 100 mM Tris-HCI, 1 M NaCI, 10 mM CaCh, 
0.01% Brij 35, 0.02% Sodium azide, pH 8.0. 7.40 mU (on 
Suc(Alah NA) were chromatographed on an agarose 6B col-
umn. Dextran blue, bovine serum albumine, trypsine and DNP 
lysine were used as markers for molecular weight. Fig 3 indi-
cates that the whole enzymatic activity eluted slightly ahead of 
bovine serum albumine. Fractions 22-29 were pooled and des-
ignated as partially purified human vulvar fibroblast elastase-
type enzyme. It has a specific activity (on Suc(Alah NA) of l.57 
m U /mg of protein. Enzyme recovery from agarose 6B chro-
matography was found greater than 80%. 
The protease was characterized by its inhibition profile as 
shown on Table 1. Clearly the elastase-type enzyme isolated 
from vulvar fibroblast is a metallo-protease being completely 
inhibited by metal chelating agents ego 1-10 phenanthrolin and 
EDT A at low molecular concentrations [18]. Its amidase activ-
ity is not affected by Pmsf nor by pepstatin and leupeptin. 
Reactivation of the enzyme after EDT A complex formation 
and dialysis against 0.1 M Tris HCl buffer pH 8.1 was not 
observed with ZnCl2 or CoCI2• 30% of the original activity of 
the protease was recovered by addition of 10 mM MgCh and a 
complete reactivation of activity was demonstrable in presence 
of similar concentration of CaCh. 
This protease was found capable of cleaving insoluble liga-
mentum nuchae elastin; 100 p.g of partially purified protease 
liberated 0.03 p.Mole of leucine equivalents after 6 hr incubation 
at 37°C. It also induced appreciable fragmentation of human 
vulva and' rabbit skin elastic fibers when applied directly to 
tissue sections (Fig 4). 
Demonstration of the In Vivo Activity of Vulva Fibroblast 
Elastase-type Protease 
In order to demonstrate its ability to degrade elastic tissue in 
vivo situation, it was injected intradermally to 3-week-old rab-
bits (500 gr weight). Solutions containing either 0.5 ml of sterile 
physiological saline (SPS), 0.5 rnl of SPS containing 0.06 mg/ 
rnl of purified leukocyte elastase, 01' 0.5 rnl of SPS containing 
0.15 mg/rnl of partially purified human vulvar fibroblast elas-
tase-type enzyme were injected intradermally to the back of 
the animals in adjacent areas. 6 hr after the initial injections, 
skin biopsies at the injection s~te were withdrawn and elastic 
fibers as well as collagen fibers were visualized in thin sections 
after orcein staining technique [12J. 
A similar loss and fragmentation of elastic fibers were de-
monstrable after injection either of human leukocyte elastase 
or human vulvar fibroblast elastase-type enzyme (see Fig 5) as 
compared with sections corresponding to the injection of sterile 
physiological saline only (see Fig 5). In order to ensure that the 
. results obtained were due to the direct elastolytic effect of the 
protease injected, both leukocyte elastase inhibited with Pmsf 
and also human vulva fibroblast elastase-type enzyme treated 
for 15 mi,n at 100°C were injected in the same way as in the 
above experiments. No difference in the state of elastic fibers 
as compared with injection of sterile physiological saline only, 
could be observed. 
In skin tissue, 2 types of elastic fibers (stained with acidified 
orcein) could be distinguished depending mainly upon their 
thickness. We arbitrarily classified as elastic fibers, those whose 
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FIG 2. Activity of Triton X-lOO extract from human vulva fibro-
blasts on Suc{Alab NA as a function of pH. Buffer: (1) 3.8 to 6.2: 100 
mM Citrate, 5 mM CaCh, 0.1% Brij 35, 0.02% NaN". (2) 7.2 to 8.85: 100 
mM Tris HCI, 5 mM CaCb, 0.1% Brij 35, 0.02% NaN". (3) 9.80 to 10.35: 
100 mM glycine, 5 mM CaCh, 0.1% Brij 35, 0.02% NaN". 65 Ilg of protein 
are incubated with buffer and Suc(Alala NA (2.5 mM final concentra-
tion) at 20°C. Abscissa: pH units. Ordinates: E lastase milli units. T he 
results represent the mean of duplicate experiments; appropriate con-
tro ls to take into account spontaneous hydrolysis of the substrate in 
different buffers are always included. 
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FIG 3. Elution profile of 3 ml (7.40 elastase units) of a human vulvar 
fibroblast extract on an agarose 6B column (2.4 X 50 cm). Elution: 0.1 
M Tris-HCl buffer pH 8.2 containing 1 M NaCI, 0.1% Brij 35 and 0.02% 
sodium azide. Temperature: 4°C - flow rate 30 ml per hr. Abcissas: 
tube number. Ordinates: Change in optical density at 280 nm--. 
Elastase ·milliunits on Suc(Alala NA-----. The arrows indicated the 
position of molecular weight markers. 
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TABLE 1. Inhibition profile of human vulvar fibroblast elastase-type 
protease" 
None 
Prosf 1 mM 
5mM 
Inhibitors and Final 
concentration 
1-10 phenanthrolin 1 mM 
EDTA 1mM 
5mM 
Pepstatin 10 f,lg/ml 
Leupeptin 10 f,lg/ml 
2 mM 
a - l antitrypsin 0.25 mg/ml 
0.50 mg/ml 
EDTA 5 mM: dialysis against 0.1 M 
tris-HCl buffer pH 8.0 
EDT A 10 mM ZnCI, 
EDTA 10 mM MgCIz 
EDTA 2.5 mM CaCh 
EDT A 5 mM CaCh 
EDT A 9 mM CaCIz 
EDT A 13 mM CaCh 
% of 
Original 
activ ity 
100 
99_0 
97.9 
00.0 
00.0 
02.3 
00.0 
98.3 
97.4 
90.0 
76.9 
00.0 
3.2 
29.8 
12.2 
40.0 
81.4 
100.0 
a Enzyme (0.094 milli Units) and inhibitor at indicated concentrations 
are previously incubated during 1 hI' at room temperature and the 
residual activity was quantitated on Suc(Alah NA. The results are 
expressed as % of original activity and represent the mean of duplicate 
experiments. 
thickness varied between 1-4 u and as elastic fibrils, those fibers 
whose thickness was between 0.3 and 0.6 u_ The lengths of both 
types of fibers were evaluated in each stained section as de-
scribed in Material and Methods: the statistical variations are 
reported on Table II. 
Injection of human vulva fibroblast elastase-type enzyme 
resulted in a considerable decrease of the average length both 
of elastic fibers and fibrils_ Interestingly, human leukocyte 
elastase was found to affect only elastic fibers but not fibrils. 
Elastic fibrils may be considered as young elastic fibers, thus 
richer in structural glycoprotein-microfibrils [2]. Therefore our 
results may indicate a proteolytic action of the fibroblast en-
ZyTIle not only on elastin but also on microfibrils. 
DISCUSSION 
Vulvar Lichen sclerosus et atrophicus (LSA) , which exhibits 
a characteristic clinical and pathological appearance has often 
been related to Lichen planus or circumscribed scleroderma. 
Nevertheless, LSA is now frequently considered as a separate 
entity of unknown etiology [19]. Histological and ultrastructural 
modifications of the skin are sometimes observed, but the most 
frequent connective tissue alterations affected mucosal areas 
[20J-
Previous reports indicated that subepidermal collagen ap-
peared edematous, structureless, and hyalinized [20]; collagen 
fibers of irregular diameter were observed with, however, ap- . 
parently normal periodicity but the chemical characteristics of 
collagen have not been reported to date in this particular tissue_ 
A 50% loss of hyaluronic acid was found by Yoshima et al 
[21] in a patient with widespread LSA. As proteoglycans play 
an important role in the hydration of tissues, and electrolyte 
balance, dermal atrophy was considered ascribable to the de-
crease of the hyaluronic acid content of the tissue. 
On the basis of histological observations, we confirmed the 
scarcity of elastic fibers in the upper dermis of patients suffering 
from LSA. In preliminary experiments (results not reported) , 
insoluble elastin was isolated from 20 vulvar biopsies by a 
sequential extraction procedure involving trichloracetic acid 
treatment of the tissue for the removal of collagen and Guani-
dinium chloride extractions to eliminate most of the structural 
glycoproteins associated with elastin [22]. In these conditions, 
a 2-3 fold statistically significant decrease of the final residual 
insoluble material analysing as elastin was demonstrable in the 
vulvas of patients suffering from LSA (in prepal-ation)_ 
Fibroblasts obtained from normal human vulvar tissue con-
tained high levels of elastase activity as compared to other 
F. L. 
.c. 
D. 
FIG 4. Histological disappearance of elastic fibers in tissue sections 
(3-5 f,I) of rabbi t skin dermis 6 ill- following the application on to the 
slide of 100 f,ll of: A, 100 mM phosphate buffer, pH 7.35. B, 100 mM 
phosphate buffer, containing 30 f,lg/ ml leu kocyte elastase_ C, 100 mM 
phosphate buffer, containing 75 f,lg/ml elastase-type protease isolated 
from human vulva fibroblast (active fraction on Suc(Alah NA eluted 
from ag'arose 6B column). EF, elastic fibers; D, dermis; FL, fatty layer; 
(orcein staining technique as described in the text, reduced from x 
1,000). 
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mesenchymal cells isolated from rat or human skin and rat 
aortic media [11). Here again, the enzymatic activity was found 
intracelluJarly and was extractible from cells with Triton X-lOO. 
This protease was partially purified by gel permeation chro-
matography and its inhibition profIle established. It is con-
sistent with its classification as a metallo-protease degrading 
Suc(Alah NA and to a lower extent insoluble ligamentum 
nuchae elastin, both maximally at slightly alkaline pH. These 
properties differentiate this enzyme from other characterized 
elastases; both pancreatic and leukocyte elastases are serine 
proteases [9] and mouse peritoneal macrophage elastase was 
found inactive towards synthetic alanine substrates including 
Suc(Alab NA [23). 
Its in vivo proteolytic action was investigated by injecting it 
intradermally to young rabbits and was compared to the elas-
tinolytic activity of purified human leukocyte elastase injected 
in the same way. Both proteases induce an important fragmen-
tation of dermal elastic fibers. This fragmentation was quant i-
fied by the measurement of the average fiber length before and 
c 
FIG 5. Histological disappearance of elastic fibers components in 
the superficial dermis of rabbits 6 hr after elastase-type enzymes 
injections. A, Intradermal injection of 30 I-'g of pUl"ified human leukocyte 
elastase. B; Injection of sterile physiological saline. C, Injection of 75 
I-'g or partially purified human vulvar fibroblast elastase-type enzyme. 
Modified Orcein staining technique (see text and reference 12) . ep, 
epidermis; sd, superficial dermis, ell , elastic fi.bers (arrows) magnifi-
cation (x 1,000). Elastic fibers: fibers wi th thickness comprised between 
7-4 1-'. The comparisons between experimental values were done ac-
cording to the Student Fisher t-test. 
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TABLE II. Decrease of rabbit shin elastic fib ers length following 
intradermal injections of purified human elastases" 
E lastic fibrils length E lastic fi bers 
(ARB-uni ts) mean l ~ngth (ARB-
va lue and (SEM) Ul1lts) mean value 
and (SEM) 
Physiological saline 28 220 
(5) (40) 
H uman leukocyte elastase 35 88 
(11) (42) 
t-value (comparison with the 1.83 7.19 
physiological saline injec tion) (P < 0.1) (P < 0.001) 
Human vulva fibroblast elastase- 17.5 15 
type enzyme (4.5) (4) 
t-value (comparison with the 5.17 ]6.14 
physiological saline injection) (p < 0.001) (p < 0.001) 
" Human leukocyte elastase (30 flg in 0.5 ml of sterile physiological 
sal ine) and partially purified human fibroblast elastase-type protease 
(751-'g in 0.5 mI of sterile physiological saline) are injected in the dermis 
of the skin of young rabbits. Six hours after injections, skin biopsies 
were performed and elastic fib ers length were estimated [12]. They 
were quantitated with a Reichert Jung Video Screen. E lastic fibrils: 
Fibers with thickness comprised between 0.3-0.6 1-'. E lastic fibers: 
diameter 1-4 1-'. 
after injections of active or inactivated enzyme. These results 
represent the first direct evidence in favor of the existence of 
proteases originating from fibroblasts capable of inducing in 
vivo fragmentation of dermal elastic fibers. 
The presence of this elastase-type protease in human vulvar 
fibroblasts is in keeping with the histological and biochemical 
observations made in LSA concerning the massive lysis of 
elastic fibers. The enzyme we isolated appears to be predomi-
nantly intracellular. It is however conceivable that under the 
effect of specific stimuli such as lymphokines for instance or 
others, this protease might be overproduced and excreted in 
the medium as was shown for neutral proteases present m 
macrophages [24). 
We thank Dr. H.P. Schnebli (CIBA Geigy, Basel) for the gift of 
purified human leukocyte elastase. 
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Bill Reed International Travelling Fellowships 
Three fellowships will be awarded this year as follows: 1. The winner of the Poster Session at the 
annual meeting of the European Society for Dermatological Research will be awarded $800 to help 
support a trip to attend the annual meeting of the American Academy of Dermatology. 2. The winner of 
the Stelwagon Prize for the best paper presented at the Resident's Forum at the annual American 
Academy of Dermatology meeting will receive an $800 award to support a trip to Europe where the 
awardee will present a paper at the annual meeting of the British Association of Dermatologists in 
England. Further travel to European centers can also be arranged. 3. A third award of $800 will be given 
to an Academically oriented dermatologist in the Private Practice of Clinical Dermatology, who has 
been out of training no more than 5 yr. It is meant to support travel for educational pm'poses and to 
broaden contacts with dermatologic investigators. Anyone interested in applying for this award should 
send their curriculum vitae and a covering letter indicating how they plan to spend the award funds, to 
the Chairman of the Committee on International Affairs of the A.A.D. at the Academy office, 1567 Maple 
Avenue, Evanston, Illinois 60201. The deadline for submission is September 1, 1982. Supporting letters 
from abroad relevant to the planned travel are desirable. The award will be announced in December and 
will be based on the originality and productivity of the applicant as well as the meritoriousness of the 
travel plans and for continued clinical investigation. 
